Background: \- Tuberculosis (TB) is an infectious disease that affects numerous people worldwide. Researchers are interested in actively recruiting individual…

Mycobacterium InfectionsTuberculosis, Multidrug-ResistantLatent Tuberculosis+2 more

~Estimated

~$10 – $675

National Institute of Allergy and Infectious Diseases (NIAID)NCT01212003

Phase 2

Six Weeks of Daily Rifapentine vs. a Comparator Arm of 12-16 Week Rifamycin-based Treatment of Latent M. Tuberculosis Infection: Assessment of Safety, Tolerability and Effectiveness

This study is conducted to compare the safety and effectiveness of a novel short 6-week regimen of daily rifapentine (6wP, experimental arm) with a comparator …

Latent Tuberculosis

~Estimated

~$10 – $5,625

Centers for Disease Control and PreventionNCT03474029

Observational

Economic Incentives and Video Directly Observed Therapy to Promote Adherence to Latent Tuberculosis Infection

The purpose of this study is to evaluate a novel and scalable intervention that combines Video Directly Observed Therapy (vDOT) and financial incentives to pro…

Latent Tuberculosis

~Estimated

~$10 – $6,250

Johns Hopkins UniversityNCT05022862